Israel Englander Graybug Vision, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.17 $73,664 - $119,763	-23,165 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.53 - $6.1 $81,772 - $141,306	23,165 New	23,165 $126,000
Q4 2020 Feb 16, 2021	SELL	$13.05 - $33.93 $1.18 Million - $3.06 Million	-90,314 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.71 - $16.5 $1.15 Million - $1.49 Million	90,314 New	90,314 $1.15 Million

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.